Literature DB >> 22189571

Duration of anticoagulation after cerebral venous sinus thrombosis.

Frances Caprio1, Richard A Bernstein.   

Abstract

Cerebral venous sinus thrombosis (CVST) often occurs in young patients and is treated with acute and then long-term oral anticoagulation. It is important to decide when to discontinue anticoagulation, as lifelong anticoagulation exposes the patient to considerable cumulative risk. However, a lack of high quality studies makes choosing a duration of anticoagulation after CVST difficult. In this article, we review the evidence for different treatment durations in several common clinical scenarios of CVST. In addition, when no direct evidence is available, we discuss and extrapolate from the more comprehensively studied situation of systemic venous thromboembolic disease. Recommendations are graded using standard criteria for the level of evidence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22189571     DOI: 10.1007/s12028-011-9661-1

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  81 in total

1.  Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis.

Authors:  Ida Martinelli; Paolo Bucciarelli; Serena M Passamonti; Tullia Battaglioli; Emanuele Previtali; Pier Mannuccio Mannucci
Journal:  Circulation       Date:  2010-06-14       Impact factor: 29.690

2.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

Authors:  John A Heit; W Michael O'Fallon; Tanya M Petterson; Christine M Lohse; Marc D Silverstein; David N Mohr; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-06-10

Review 3.  [Vascular cerebral thrombosis during pregnancy and post-partum].

Authors:  P François; M Fabre; E Lioret; M Jan
Journal:  Neurochirurgie       Date:  2000-04       Impact factor: 1.553

Review 4.  Familial thrombophilia: a complex genetic disorder.

Authors:  B P Koeleman; P H Reitsma; R M Bertina
Journal:  Semin Hematol       Date:  1997-07       Impact factor: 3.851

5.  Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism.

Authors:  Ingrid Pabinger; Helga Grafenhofer; Paul A Kyrle; Peter Quehenberger; Christine Mannhalter; Klaus Lechner; Alexandra Kaider
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

Review 6.  Risk factors of cerebral vein and sinus thrombosis.

Authors:  Gabriel R de Freitas; Julien Bogousslavsky
Journal:  Front Neurol Neurosci       Date:  2008

7.  Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis.

Authors:  M Coppens; J H Reijnders; S Middeldorp; C J M Doggen; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2008-06-06       Impact factor: 5.824

8.  Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems.

Authors:  Thomas Bombeli; Adila Basic; Joerg Fehr
Journal:  Am J Hematol       Date:  2002-06       Impact factor: 10.047

Review 9.  Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.

Authors:  E Steve Roach; Meredith R Golomb; Robert Adams; Jose Biller; Stephen Daniels; Gabrielle Deveber; Donna Ferriero; Blaise V Jones; Fenella J Kirkham; R Michael Scott; Edward R Smith
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

10.  High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.

Authors:  I Martinelli; E Sacchi; G Landi; E Taioli; F Duca; P M Mannucci
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

View more
  4 in total

Review 1.  Neurological Complications of Pregnancy.

Authors:  H Steven Block
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

Review 2.  Etiologies of intracerebral hematomas.

Authors:  Qingliang T Wang; Stanley Tuhrim
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

3.  Cerebral Venous Sinus Thrombosis during Everest Expedition: A Case Report and Review of the Literature.

Authors:  P Khanal; L Thapa; A M Shrestha; S Bhattarai; D Sapkota; N Sharma; U P Devkota
Journal:  Case Rep Neurol Med       Date:  2016-10-31

4.  Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review.

Authors:  Gauruv Bose; Justin Graveline; Vignan Yogendrakumar; Risa Shorr; Dean A Fergusson; Gregoire Le Gal; Jonathan Coutinho; Marcelo Mendonça; Miguel Viana-Baptista; Simon Nagel; Dar Dowlatshahi
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.